SCHEMBL7835080

SCHEMBL7835080

[CH2]c1ccc(OCC(C)C)c2ccccc12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.42
▸ GAA P10253 1/20 0.42
▸ DHODH Q02127 2/20 0.41
▸ CYP2D6 P10635 6/20 0.40
▸ TLR8 Q9NR97 1/20 0.40
▸ SLC2A1 P11166 1/20 0.39
▸ CYP1A2 P05177 5/20 0.39
▸ KDM4E B2RXH2 2/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ CYP2C19 P33261 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ NR2E1 Q9Y466 4/20 0.39
▸ ELANE P08246 1/20 0.38
▸ ADRB2 P07550 3/20 0.37
▸ ADRB1 P08588 3/20 0.37
▸ HTR2C P28335 3/20 0.37
▸ SLC6A4 P31645 3/20 0.37
▸ HTR2B P41595 3/20 0.37
▸ SIGMAR1 Q99720 3/20 0.37
▸ ADRB3 P13945 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31599179 0.89 ALDH1A1 (0.50) ALDH1A1GAADHODHCYP2D6TLR8
SCHEMBL17912799 0.89 ALDH1A1 (0.50) ALDH1A1GAADHODHCYP2D6TLR8
SCHEMBL6123816 0.81 IDO1 (0.50) ALDH1A1GAADHODHCYP2D6TLR8
SCHEMBL7835082 0.80 CYP1A2 (0.48) ALDH1A1GAADHODHCYP2D6TLR8
SCHEMBL2023749 0.79 IDO1 (0.59) ALDH1A1GAADHODHCYP2D6TLR8
SCHEMBL6111393 0.77 HTR2C (0.44) ALDH1A1GAACYP2D6TLR8CYP1A2
SCHEMBL7823246 0.76 CYP1A2 (0.45) ALDH1A1GAATLR8CYP1A2MEN1
SCHEMBL29829725 0.74 NR2E1 (0.64) ALDH1A1CYP2D6CYP1A2KDM4EMEN1
SCHEMBL5031818 0.74 NR2E1 (0.64) ALDH1A1CYP2D6CYP1A2KDM4EMEN1
SCHEMBL4334443 0.74 ALDH1A1 (0.55) ALDH1A1GAATLR8CYP1A2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0676398-B1 Heterocyclic compounds having anti-diabetic activity, their preparation and their use SANKYO CO (JP) 2001-10-24 — — EP disclosed
CN-1066729-C Benzimidazole derivatives, their preparation and their therapeutic use SANKYO CO (JP) 2001-06-06 — — CN disclosed
US-6117893-A Heterocyclic compounds having anti-diabetic activity and their use SANKYO COMPANY, LIMITED (JP) 2000-09-12 — — US disclosed
EP-1022274-A1 Oxazolidinedione and Thiazolidinedione derivatves, their preparation and their use Sankyo Company Limited (JP) 2000-07-26 — — EP disclosed
US-5977365-A HYPOGLYCEMIC AGENTS SANKYO COMPANY, LIMITED (JP) 1999-11-02 — — US disclosed
US-5962470-A Heterocyclic compounds having anti-diabetic activity and their use SANKYO COMPANY, LIMITED (JP) 1999-10-05 — — US disclosed
US-5886014-A TREATMENT AND/OR PROPHYLAXIS OF A VARIETY OF DISORDERS, INCLUDING HYPERLIPEMIA, HYPERGLYCEMIA, OBESITY, IMPAIRED GLUCOSE TOLERANCE (IGT), INSULIN RESISTANCE AND DIABETIC COMPLICATIONS SANKYO COMPANY, LIMITED (JP) 1999-03-23 — — US disclosed
US-5834501-A TREATING DIABETES OR HYPERLIPEMIA SANKYO COMPANY, LIMITED (JP) 1998-11-10 — — US disclosed
US-5739345-A HYPOGLYCEMIC AND ANTIDIABETIC AGENTS SANKYO COMPANY, LIMITED (JP) 1998-04-14 — — US disclosed
CN-1157288-A Benzimidazole derivatives, their preparation and their therapeutic use SANKYO CO (JP) 1997-08-20 — — CN disclosed
US-5624935-A ANTIDIABETIC AGENTS, HYPOGLYCEMIC AGENTS OR ANTILIPEMIC AGENTS SANKYO COMPANY, LIMITED 1997-04-29 — — US disclosed
EP-0745600-A1 Benzimidazole derivatives, their preparation and their therapeutic use SANKYO COMPANY LIMITED (JP) 1996-12-04 — — EP disclosed
EP-0676398-A2 Heterocyclic compounds having anti-diabetic activity, their preparation and their use SANKYO COMPANY LIMITED (JP) 1995-10-11 — — EP disclosed
Send feedback